Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Abozaid

, Kerr

, Alomary

, et al. Global insight into rare disease and orphan drug definitions: A systematic literature review. BMJ Open, 2025; 15(1):e086527; doi: 10.1136/bmjopen-2024-086527

Gabbal

. Kevin Ashton describes “the internet of things.” The innovator weighs in on what human life will be like a century from now. Smithsonian Magazine. 2015 January issue. Available from: www.smithsonianmag.com/innovation/kevin-ashtondescribes-the-internet-of-things-180953749 [Last accessed: October 22, 2025].

Ghadessi

, Di

, Wang

, et al. Decentralized clinical trials and rare diseases: A Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective. Orphanet J Rare Dis, 2023; 18(1):79; doi: 10.1186/s13023-023-02693-7

Loru

, Nudo

, Di Marco

, et al. The simulation of judgment in LLMs. Proc Natl Acad Sci U S A, 2025; 122(42):e2518443122; doi: 10.1073/pnas.2518443122

Sato

, Ishimaru

, Takata

, et al. Application of internet of medical/health things to decentralized clinical trials: Development status and regulatory considerations. Front Med (Lausanne), 2022; 9:903188; doi: 10.3389/fmed.2022.903188

Letter: The Internet of Medical Things (IoMT): A New Frontier in the Digital Age for Rare Disease Clinical Trials and Global Drug Development

Abstract

Get full access to this article

References